Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4751–4800 of 34692
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
On January 31, 2025, the Board of Directors (the “Board”) of Aviat Networks, Inc. (“Aviat” or the “Company”) approved the appointment of Mr. Scott Halliday as a director of the Board, effective immediately
On January 29, 2025, the Board appointed Andrew Johnson as a director, effective on January 30, 2025, to fill an existing vacancy on the Board.
On January 29, 2025, Christopher Sambar notified the Board of Directors (the “Board”) of AST SpaceMobile, Inc. (the “Company”) of his decision to resign as the designee of AT&T Venture Investments, LLC (“AT&T”) from the Board, effective on the same date.
On January 29, 2025, upon the nomination of AT&T, the Board appointed Keith Larson as a director, effective on January 30, 2025, to fill the vacancy on the Board as designee of AT&T created by Mr. Sambar’s resignation.
the Board of Directors of the Company (the “ Board ”) increased the size of the Board by one director and appointed Darin G. Holderness to the resulting vacancy (the “ Appointment ”).
On January 30, 2025, the Board appointed Scott I. Ross, 44, to the Board and to the Nominating and Corporate Governance Committee and Finance Committee of the Board, in each case effective January 30, 2025
On January 28, 2025, the Board of Directors of Forward Industries, Inc. (the “Company”) appointed Michael Pruitt as a director of the Company, as well as a member of the Audit and Risk Committee and Nominating Committee, effective February 1, 2025.
Following the appointment of Ms. Calero, Rodolfo Guerrero Angulo resigned as an executive officer and a director of the Company
and Marquez Hernandez Maria De Lourdes resigned as a director of the Company.
the Board also approved an increase in the size of the Board from eight to nine directors, and appointed Mr. Desmond as a Class II Director, effective February 1, 2025.
On January 30, 2025, Robert Chapek notified the Board of Directors (the “Board”) of Masimo Corporation (“Masimo”) of his irrevocable resignation from the Board and all committees thereof, effective as of the date of the 2025 annual meeting of Masimo, which date the Board has not determined at this time.
appointed Mr. Brian Leach to fill the resulting vacancy.
On January 28, 2025, Ronald E. Blaylock, a member of the board of directors (the “Board”) of CarMax, Inc. (the “Company”), informed the Company that he would not stand for reelection as a member of the Board at the Company’s 2025 annual meeting of shareholders.
Scott W. Wine notified the Board that he does not intend to stand for re-election to the Company’s Board of Directors following expiration of his current term at the Company’s 2025 Annual Meeting of Shareholders.
In connection with and effective upon the closing of the Mergers, Deborah G. Adams, Tiffany Thom Cepak and Leldon E. Echols resigned as directors of the Manager.
In connection with and effective upon the closing of the Mergers, Deborah G. Adams, Tiffany Thom Cepak and Leldon E. Echols resigned as directors of the Manager.
In connection with and effective upon the closing of the Mergers, Deborah G. Adams, Tiffany Thom Cepak and Leldon E. Echols resigned as directors of the Manager.
On January 28, 2025, Benjamin G. Ruddy notified the Eagle Bancorp Montana, Inc. (the “Company”) Board of Directors (the “Board”) of his decision to resign, for personal reasons, from the Company’s Board and the Board of Directors of its wholly-owned subsidiary Opportunity Bank of Montana, effective immediately.
On January 31, 2025, the Board, upon the recommendation of the Nominating and Governance Committee of the Board (“Nominating Committee”), appointed Nick Miaritis as a Class II member of the Board to fill a vacancy arising from Mr. Kelly’s departure.
On January 27, 2025, Tom Kelly, a member of the Board of Directors (the “Board”), notified The Scotts Miracle-Gro Company (the “Company”) of his resignation from the Board with his term ending January 31, 2025.
On January 28, 2025, Greenwave Technology Solutions, Inc. (“Greenwave” or the “Company”) increased the number of directors comprising its Board of Directors (“Board”) from four to five members and appointed Lisa Lucas-Burke as a member of the Board and as a member of the Audit Committee, Compensation Committee, and Nomination and Corporate Governance Committee (collectively, the “Committees”), effective immediately.
On January 29, 2025, the Board of Directors (the “Board”) of Ultra Clean Holdings, Inc. (the “Company”) appointed Joanne Solomon to serve as a member of the Board of the Company, effective February 3, 2025.
On January 27 and 28, 2025, each of Vijay Pande and Michael Altman, respectively, informed Nautilus Biotechnology, Inc. (the “Company”) that they will not stand for re-election to the Company’s board of directors at the Company’s 2025 annual meeting of stockholders.
On January 27 and 28, 2025, each of Vijay Pande and Michael Altman, respectively, informed Nautilus Biotechnology, Inc. (the “Company”) that they will not stand for re-election to the Company’s board of directors at the Company’s 2025 annual meeting of stockholders.
On January 29, 2025, the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) increased the size of the Board to 11 directors and appointed William Valle as a Class I director of the Company and Gary Gordon as Class III director of the Company, with their term of office expiring at the 2027 and 2026 annual meeting of stockholders, respectively.
On January 29, 2025, the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) increased the size of the Board to 11 directors and appointed William Valle as a Class I director of the Company and Gary Gordon as Class III director of the Company, with their term of office expiring at the 2027 and 2026 annual meeting of stockholders, respectively.
Harry V. Barton, Jr., age 70, informed FHN that he will retire from the Board effective when directors are elected at the 2025 annual meeting of shareholders.
elected Jeffrey J. Brown to the Board, effective immediately.
On January 28, 2025, the Board of Directors (the “Board”) of Kennametal Inc. (the “Company”) announced the appointment of Doug Dietrich, age 55, to serve as a member of the Board of Directors to hold office from February 1, 2025 until the Annual Meeting of Shareholders in October 2025
On January 27, 2025, Candace Matthews, a member of the Board of Directors of MillerKnoll, Inc. (the “Company”) advised the Board that she was resigning from the Board effective February 15, 2025.
elected Richard S. Stoddart to the Board, in each case, effective February 3, 2025.
On January 29, 2025, Bogota Financial Corp. (the “Company”) appointed Peter T. Donnelly to the board of directors of the Company, effective March 26, 2025.
On January 29, 2025, Mr. John C. Gordon, a member of the Board of Directors (the “Board”) of First US Bancshares, Inc. (the “Company”), notified the Company of his resignation as a director of the Company effective January 31, 2025.
On January 24, 2025, Mr. John Wilson resigned from the Board of Directors of Marker Therapeutics, Inc.
On January 27, 2025, Eric Speron resigned as a member of the Company’s Board of Directors and its Compensation Committee, effective as of January 31, 2025.
Troy W. Thacker notified the Company that he has made the decision not to stand for re-election at the 2025 Annual Meetings
appointed Timothy A. Roberts and Bruce E. Cope, CPA to the Board, effective as of January 24, 2025
appointed Timothy A. Roberts and Bruce E. Cope, CPA to the Board, effective as of January 24, 2025
On January 29, 2025, the board of directors of Lantheus Holdings, Inc. (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Phuong Khanh (P.K.) Morrow, M.D., an experienced pharmaceutical executive and physician-scientist with deep expertise leading end-to-end clinical development in the field of oncology, to the Board.
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
the Board unanimously appointed Irving Tan, Bruce Kiddoo and Roxanne Oulman to the Board, effective upon, and subject to, the consummation of the Spin-Off.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.